KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $10.5 million.

  • Idexx Laboratories' Gains from Investment Securities fell 61.01% to $85,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year decrease of 31.55%. This contributed to the annual value of $10.5 million for FY2024, which is 5.57% up from last year.
  • Per Idexx Laboratories' latest filing, its Gains from Investment Securities stood at $10.5 million for FY2024, which was up 5.57% from $10.0 million recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Gains from Investment Securities registered a high of $20.6 million during FY2020, and its lowest value of $10.0 million during FY2023.
  • Moreover, its 3-year median value for Gains from Investment Securities was $10.5 million (2024), whereas its average is $10.4 million.
  • Per our database at Business Quant, Idexx Laboratories' Gains from Investment Securities surged by 155.84% in 2020 and then slumped by 31.85% in 2022.
  • Over the past 5 years, Idexx Laboratories' Gains from Investment Securities (Yearly) stood at $20.6 million in 2020, then declined by 24.47% to $15.6 million in 2021, then slumped by 31.85% to $10.6 million in 2022, then declined by 5.95% to $10.0 million in 2023, then rose by 5.57% to $10.5 million in 2024.